🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary scientific question of interest of this study is whether the co...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-09-15
Trial ID
NCT05809895
Treatments Being Tested
Neoadjuvant Short-Course Radiotherapy Followed by Tislelizumab Plus Chemoth...
Status
Not Yet Recruiting
Location
Tangdu Hospital, Fourth Military Medical University
Start Date
2026-07-10
Trial ID
NCT07678580
This is a multicenter, open-label, prospective, single-arm, phase II study ...
Status
Recruiting
Location
Fujian Medical University Union Hospital
Start Date
2025-10-25
Trial ID
NCT07296705
Treatments Being Tested
This phase II trial employs a prospective, randomized, parallel-group desig...
Status
Recruiting
Location
Sun yat-sen University Cancer Center
Start Date
2026-06-01
Trial ID
NCT07609121
Treatments Being Tested
A prospective, randomized, open-label, multicenter Phase 3 trial designed t...
Status
Recruiting
Location
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Start Date
2022-10-28
Trial ID
NCT05582265
To determine the optimal objective response rate (ORR) of tislelizumab comb...
Status
Active Not Recruiting
Location
The First Affiliated Hospital of Guangzhou Medical University
Start Date
2020-11-06
Trial ID
NCT07638878
Treatments Being Tested
Esophageal cancer is one of the most common malignancies in China, and esop...
Status
Recruiting
Location
Cancer Hospital of Shantou University Medical College
Start Date
2023-08-02
Trial ID
NCT05984342
Treatments Being Tested
This study is designed as an open-label, single-arm, single center, phase I...
Status
Recruiting
Location
The Second Hospital of Tianjin Medical University
Start Date
2025-07-05
Trial ID
NCT07126119
Treatments Being Tested
This study is testing whether adding three drugs, All-Trans Retinoic Acid (...
Status
Not Yet Recruiting
Location
Verspeeten Family Cancer Centre
Start Date
2026-02-15
Trial ID
NCT07348107
Treatments Being Tested
To evaluate the efficacy of Tislelizumab combined with Nab-paclitaxel and G...
Status
Unknown
Location
Changhai Hospital
Start Date
2020-11-20
Trial ID
NCT04902261
Treatments Being Tested